REPORT ID 2915

Global Antibody-drug Conjugates Market Research Report 2017

Publish Date
12-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the global Antibody-drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antibody-drug Conjugates in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Antibody-drug Conjugates market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    ImmunoGen
    Seattle Genetics
    Roche
    Takeda
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Adcetris
    Kadcyla
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Breast Cancer
    Lymphoma

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Antibody-drug Conjugates Market Research Report 2017
1 Antibody-drug Conjugates Market Overview
    1.1 Product Overview and Scope of Antibody-drug Conjugates
    1.2 Antibody-drug Conjugates Segment by Type (Product Category)
        1.2.1 Global Antibody-drug Conjugates Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Antibody-drug Conjugates Production Market Share by Type (Product Category) in 2016
        1.2.3 Adcetris
        1.2.4 Kadcyla
    1.3 Global Antibody-drug Conjugates Segment by Application
        1.3.1 Antibody-drug Conjugates Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
    1.4 Global Antibody-drug Conjugates Market by Region (2012-2022)
        1.4.1 Global Antibody-drug Conjugates Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Antibody-drug Conjugates (2012-2022)
        1.5.1 Global Antibody-drug Conjugates Revenue Status and Outlook (2012-2022)
        1.5.2 Global Antibody-drug Conjugates Capacity, Production Status and Outlook (2012-2022)

2 Global Antibody-drug Conjugates Market Competition by Manufacturers
    2.1 Global Antibody-drug Conjugates Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Antibody-drug Conjugates Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Antibody-drug Conjugates Production and Share by Manufacturers (2012-2017)
    2.2 Global Antibody-drug Conjugates Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
        2.5.1 Antibody-drug Conjugates Market Concentration Rate
        2.5.2 Antibody-drug Conjugates Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody-drug Conjugates Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Antibody-drug Conjugates Capacity and Market Share by Region (2012-2017)
    3.2 Global Antibody-drug Conjugates Production and Market Share by Region (2012-2017)
    3.3 Global Antibody-drug Conjugates Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Antibody-drug Conjugates Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Antibody-drug Conjugates Consumption by Region (2012-2017)
    4.2 North America Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
    4.4 China Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
    4.7 India Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)

5 Global Antibody-drug Conjugates Production, Revenue (Value), Price Trend by Type
    5.1 Global Antibody-drug Conjugates Production and Market Share by Type (2012-2017)
    5.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
    5.3 Global Antibody-drug Conjugates Price by Type (2012-2017)
    5.4 Global Antibody-drug Conjugates Production Growth by Type (2012-2017)

6 Global Antibody-drug Conjugates Market Analysis by Application
    6.1 Global Antibody-drug Conjugates Consumption and Market Share by Application (2012-2017)
    6.2 Global Antibody-drug Conjugates Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Antibody-drug Conjugates Manufacturers Profiles/Analysis
    7.1 ImmunoGen
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Antibody-drug Conjugates Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 ImmunoGen Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Seattle Genetics
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Antibody-drug Conjugates Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Seattle Genetics Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Roche
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Antibody-drug Conjugates Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Roche Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Takeda
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Antibody-drug Conjugates Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Takeda Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    ...

8 Antibody-drug Conjugates Manufacturing Cost Analysis
    8.1 Antibody-drug Conjugates Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Antibody-drug Conjugates

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Antibody-drug Conjugates Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Antibody-drug Conjugates Market Forecast (2017-2022)
    12.1 Global Antibody-drug Conjugates Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Antibody-drug Conjugates Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Antibody-drug Conjugates Price and Trend Forecast (2017-2022)
    12.2 Global Antibody-drug Conjugates Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Antibody-drug Conjugates Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Antibody-drug Conjugates Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer